JP2018513138A5 - - Google Patents

Download PDF

Info

Publication number
JP2018513138A5
JP2018513138A5 JP2017550832A JP2017550832A JP2018513138A5 JP 2018513138 A5 JP2018513138 A5 JP 2018513138A5 JP 2017550832 A JP2017550832 A JP 2017550832A JP 2017550832 A JP2017550832 A JP 2017550832A JP 2018513138 A5 JP2018513138 A5 JP 2018513138A5
Authority
JP
Japan
Prior art keywords
dosage form
weight
polyethylene glycol
polyvinyl alcohol
russia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017550832A
Other languages
English (en)
Japanese (ja)
Other versions
JP6713483B2 (ja
JP2018513138A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/025176 external-priority patent/WO2016161069A1/en
Publication of JP2018513138A publication Critical patent/JP2018513138A/ja
Publication of JP2018513138A5 publication Critical patent/JP2018513138A5/ja
Application granted granted Critical
Publication of JP6713483B2 publication Critical patent/JP6713483B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017550832A 2015-04-02 2016-03-31 ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形 Active JP6713483B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562141981P 2015-04-02 2015-04-02
US62/141,981 2015-04-02
PCT/US2016/025176 WO2016161069A1 (en) 2015-04-02 2016-03-31 Combination dosage form of a mu opioid receptor antagonist and an opioid agent

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020016858A Division JP2020073583A (ja) 2015-04-02 2020-02-04 ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形

Publications (3)

Publication Number Publication Date
JP2018513138A JP2018513138A (ja) 2018-05-24
JP2018513138A5 true JP2018513138A5 (https=) 2019-03-14
JP6713483B2 JP6713483B2 (ja) 2020-06-24

Family

ID=55806767

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017550832A Active JP6713483B2 (ja) 2015-04-02 2016-03-31 ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形
JP2020016858A Withdrawn JP2020073583A (ja) 2015-04-02 2020-02-04 ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020016858A Withdrawn JP2020073583A (ja) 2015-04-02 2020-02-04 ミューオピオイド受容体アンタゴニストとオピオイド剤との組み合わせ剤形

Country Status (27)

Country Link
US (4) US20160287573A1 (https=)
EP (1) EP3277278B1 (https=)
JP (2) JP6713483B2 (https=)
KR (1) KR20170132325A (https=)
CN (1) CN107820424B (https=)
AU (1) AU2016243691A1 (https=)
BR (1) BR112017021120A2 (https=)
CA (1) CA2980328A1 (https=)
CY (1) CY1122828T1 (https=)
DK (1) DK3277278T3 (https=)
ES (1) ES2774473T3 (https=)
HK (1) HK1247105A1 (https=)
HR (1) HRP20200432T1 (https=)
HU (1) HUE048785T2 (https=)
IL (1) IL254593A0 (https=)
LT (1) LT3277278T (https=)
ME (1) ME03671B (https=)
MX (1) MX2017012474A (https=)
PH (1) PH12017501767A1 (https=)
PL (1) PL3277278T3 (https=)
PT (1) PT3277278T (https=)
RS (1) RS60074B1 (https=)
RU (1) RU2017134794A (https=)
SI (1) SI3277278T1 (https=)
SM (1) SMT202000157T1 (https=)
TW (1) TW201642856A (https=)
WO (1) WO2016161069A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3277278T3 (da) 2015-04-02 2020-04-06 Theravance Biopharma R&D Ip Llc Kombinationsdoseringsform af en my-opioid receptorantagonist og et opioid
EP3666261B1 (en) 2017-08-08 2025-01-15 Mitsubishi Chemical Corporation Pharmaceutical tablet and method for producing same

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1041987B1 (en) 1997-12-22 2006-04-19 Euro-Celtique S.A. Pharmaceutical oral dosage form comprising a combination of an opioid agonist and naltrexone
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
US7842307B2 (en) 2001-08-06 2010-11-30 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
IL160222A0 (en) * 2001-08-06 2004-07-25 Euro Celtique Sa Opioid agonist formulations with releasable and sequestered antagonist
EP1572164A2 (en) * 2002-12-18 2005-09-14 Pain Therapeutics, Inc. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
KR20060092255A (ko) 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
TWI354569B (en) 2004-05-28 2011-12-21 Bristol Myers Squibb Co Coated tablet formulation and method
CN101163701A (zh) * 2005-03-02 2008-04-16 施万制药 作为5-ht4受体激动剂的喹啉酮化合物
CN101395154B (zh) * 2006-03-01 2011-01-19 施万制药 作为μ阿片受体拮抗剂的8-氮杂双环[3.2.1]辛烷化合物
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
CN101500542A (zh) * 2006-07-11 2009-08-05 共有药物有限公司 控释制剂
TWI409067B (zh) 2007-02-28 2013-09-21 Theravance Inc 8-氮雜雙環〔3.2.1〕辛烷化合物之結晶型
TWI415850B (zh) 2007-07-20 2013-11-21 Theravance Inc 製備mu類鴉片受體拮抗劑之中間物的方法
WO2009137672A1 (en) * 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
EP2210595A1 (en) 2009-01-14 2010-07-28 LEK Pharmaceuticals d.d. Active coating of pharmaceutical dosage forms
KR101783945B1 (ko) * 2009-05-12 2017-10-10 비피에스아이 홀딩스, 엘엘씨. 향상된 수분차단 속방출형 필름의 코팅 시스템 및 이에 의하여 코팅된 기재
IT1398930B1 (it) * 2010-03-24 2013-03-28 Molteni & C Formulazioni farmaceutiche bistrato contenenti agonisti ed antagonisti oppioidi.
CN103370064A (zh) * 2010-09-03 2013-10-23 百时美施贵宝公司 使用水溶性抗氧化剂的药物制剂
CA2826391C (en) 2011-02-01 2017-01-24 Bristol-Myers Squibb Company Pharmaceutical formulations including an amine compound
US9339489B2 (en) * 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
DK3277278T3 (da) 2015-04-02 2020-04-06 Theravance Biopharma R&D Ip Llc Kombinationsdoseringsform af en my-opioid receptorantagonist og et opioid

Similar Documents

Publication Publication Date Title
RU2127587C1 (ru) Устойчивые лекарственные формы с регулируемым выделением, имеющие акриловые полимерные покрытия, (варианты) и способ их получения
JP2008280351A5 (https=)
CA2561109A1 (en) Gastric retention system
JPS61176521A (ja) 投与形態物の処理方法
FI3562486T3 (fi) Kielenalaisen deksmedetomidiinin käyttö agitaation hoidossa
JP2010510260A5 (https=)
JP2018514523A5 (https=)
BR112016001822B1 (pt) Comprimido farmacêutico compreendendo ácido acetilsalicílico e clopidogrel e seu processo de fabricação
JP2014503523A5 (https=)
JP2016515523A5 (https=)
RU2013141534A (ru) Составы l-ментола, состоящие из множества частиц, и связанные с ними способы
CN108367078A (zh) 医药微丸的干粉包衣组合物
JP2010540547A5 (https=)
HRP20211269T1 (hr) Kompozicije prolijeka na bazi monometil fumarata
JP2019509345A5 (https=)
CZ2015272A3 (cs) Polymerní film s obsahem fotosensitizérů a jeho použití
Osei-Yeboah et al. A top coating strategy with highly bonding polymers to enable direct tableting of multiple unit pellet system (MUPS)
WO2012053785A3 (ko) 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛
JP2015508411A5 (https=)
JP2018513138A5 (https=)
Muschert et al. Improved long term stability of aqueous ethylcellulose film coatings: importance of the type of drug and starter core
JP5973170B2 (ja) 固体分子分散物
JP2015120758A5 (https=)
WO2016091805A3 (de) Naloxon-monopräparat und mehrschichttablette
JP2016033133A5 (https=)